InvestorsHub Logo
Followers 1
Posts 972
Boards Moderated 0
Alias Born 02/14/2018

Re: CATTDOGG12347 post# 92694

Thursday, 02/14/2019 1:35:30 PM

Thursday, February 14, 2019 1:35:30 PM

Post# of 108192

Merck is initiating three new pivotal prostate cancer trials: KEYLYNK-010 (Keytruda + Lynparza), KEYNOTE-921 (Keytruda + docetaxel and prednisone) and KEYNOTE-621 (Keytruda + Xtandi)


There’s your 3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News